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ABSTRACT
Background: Depression is a risk factor for adverse out-
comes following myocardial infarction (MI). However, the
importance of various other psychological factors is less well
established. Purpose: The purpose is (a) explore the degree
to which self-reported psychological symptoms in post-MI
patients represent one or more underlying dimensions and
(b) examine whether psychological symptom profiles based
on these dimensions are differentially associated with major
depressive disorder (MDD) and anxiety disorder (AD), and
impaired health status. Methods: Two months post-MI, the
Beck Depression Inventory, State-Trait Anxiety Inventory,
and Global Mood Scale were used to measure symptoms of
depression, anxiety, and mood status in 324 patients. The
Composite International Diagnostic Interview was adminis-
tered to diagnose DSM-IV MDD and AD. Health status
was assessed by the Seattle Angina Questionnaire. Results:
Principal component analysis revealed 4 essential features of
post-MI distress: depressed affect, anxious apprehension, posi-
tive affect, and emotional exhaustion. Cluster analysis using
these components identified 3 subgroups with different symp-
tom profiles: A no distress subgroup (high positive affect,
low on the remaining components), a first increased distress
subgroup (ID1; elevated anxious apprehension=emotional
exhaustion scores and decreased positive affect, p < .001, but
absence of depressed affect, p ¼ .56), and a second increased
distress subgroup (ID2; decreased positive affect and elevated
scores on the other components, all p < .001). Both increased
distress subgroups were more likely to have psychiatric dis-
order (ID1: odds ratio [OR] ¼ 5.4, 95% confidence interval
[CI] ¼ 1.3–22.1, p ¼ .018; ID2: OR ¼ 27.1, 95%
CI ¼ 6.4–114.7, p < .0001) and worse health status (ID1:
 .38 < b < .12; all p < .05; ID2:  .48 < b < .20; all
p < .05). Conclusions: In addition to standard depressive
symptoms, other affective components are important in under-
standing emotional adjustment in post-MI patients. These com-
ponents are closely related to psychiatric comorbidity and poor
health status post-MI.
(Ann Behav Med 2007, 34(1):87–94)
INTRODUCTION
About one in five patients is affected by major depress-
ive disorder (MDD) following myocardial infarction (MI)
(1). In turn, both MDD and depressive symptoms have
been associated with (a) a twofold increased risk of mor-
tality and (b) increased morbidity and rehospitalisation
post-MI (2–6). Although several literature reviews have
concluded that there is evidence that various other psycho-
logical factors are related to prognosis in established cor-
onary artery disease (CAD) (7–9), the importance of
these factors is less well established. In addition, it is not
known which symptoms are specific to post-MI distress
and whether there are reliably identifiable subgroups of
post-MI patients with different psychological symptom
profiles.
According to Frasure-Smith and Lespe´rance (10), most
studies on psychosocial risk factors in CAD patients used
only one psychological or social variable, making it imposs-
ible to examine the degree to which the variables represent
one or more common dimensions. Without using multiple
measures, it is difficult to know whether the essential fea-
tures of distress in post-MI patients concern specific
psychological concepts or one or more underlying dimen-
sions, including negative affectivity. In addition, little is
known about the psychological symptom profiles based
on these dimensions and their relationship with adverse out-
comes post-MI. Identification of CAD risk profiles across
the spectrum of symptoms and syndromes characterizing
psychological discomfort, including subsyndromal con-
ditions, might increase the sensitivity of our epidemiologic
prediction models and clarify the pathophysiological path-
ways linking negative psychological states to CAD (11).
The objectives of this study were (a) to explore the
degree to which psychological variables of distress in
post-MI patients represent one or more underlying dimen-
sions and (b) to examine whether psychological symptom
profiles based on these dimensions are differentially asso-
ciated with the Diagnostic and Statistical Manual of Mental
Disorders (4th ed. [DSM–IV]) (12) MDD and anxiety dis-
order (AD) and impaired self-reported health status.
METHODS
Patient Population and Design
Between May 2003 and August 2005, 402 patients hos-
pitalized for acute MI were recruited from four teaching
hospitals (Catharina Hospital, Eindhoven; St. Elisabeth
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Hospital, Tilburg; TweeSteden Hospital, Tilburg; and
St. Anna Hospital, Geldrop) in the Netherlands. Two
months post-MI, during an appointment specifically for
this study, patients were evaluated by a trained psychol-
ogist using the Composite International Diagnostic Inter-
view (CIDI) (13) and completed self-report measures of
depression, anxiety, emotional distress, and disease-specific
health status in the cardiology department of the partici-
pating hospitals. Inclusion criteria were age above 30 and
hospitalization due to acute MI. Exclusion criteria were
significant cognitive impairments (e.g., dementia), severe
comorbidities (e.g., cancer) in addition to their cardiac con-
dition, and psychiatric comorbidities other than MDD and
AD (e.g., psychosis). Criteria for the diagnosis of MI
included troponin I levels more than twice the upper limit,
with typical ischemic symptoms (e.g., chest pain) lasting for
more than 10min or electrocardiogram (ECG) evidence of
ST segment elevation or new pathological Q-waves. The
study was approved by the medical ethics committees of
the participating hospitals. The study was conducted in
accordance with the Helsinki Declaration, and all patients
provided written informed consent.
Analyses were based on patients who were alive 2
months after discharge from the index hospitalization for
MI, who were assessed with the CIDI and had completed
the self-report questionnaires 2 months post-MI. Of the
original 402 patients, 10 patients refused to participate at
2 months follow-up, 5 patients died prior to the 2-months
assessment, and 63 patients were excluded due to missing
CIDI diagnosis or missing self-report measures. Hence,
the final population for this study comprised 324 patients.
Measures
Symptoms of depression, anxiety, and mood status. The
Beck Depression Inventory (BDI) is a 21-item self-report
measure developed to assess the presence and severity of
depressive symptoms during the past week (14). Each item is
rated on a 0 to 3 scale. The BDI is a reliable and well-
validated measure of depressive symptomatology (15,16)
and is the most widely used self-report measure of
depression. BDI scores 10 or higher are indicative of at least
mild to moderate symptoms of depression and have been
associated with poor prognosis in MI patients (4,6,17,18).
The State-Trait Anxiety Inventory (STAI) is a self-
report measure consisting of two 20-item scales developed
to measure the level of general state and trait anxiety
(19). In this study we included the state scale of the STAI,
which assesses the current level of general anxiety. Each
item is rated on a 4-point Likert scale. Elevated scores on
the STAI have been associated with poor prognosis in
MI patients (20). The STAI has been demonstrated to have
adequate validity and reliability (21).
The Global Mood Scale (GMS) is a self-report mea-
sure assessing both positive (energy and sociability) and
negative (fatigue and malaise) mood states in patients with
heart disease (22). It consists of 10 positive and 10 negative
mood terms answered on a 5-point Likert scale. The
respondent is asked to rate the extent to which he or she
has experienced each mood state lately. The GMS has been
shown to be a valid and reliable measure of affective mood
states (22,23) and is very responsive to treatment-related
changes in mood status (24).
Clinical diagnoses of depression and anxiety disorder. The
CIDI was used to assess current diagnoses of MDD and AD
(consisting of panic disorder, social phobia, and=or
generalized anxiety disorder) based on the diagnostic
criteria of the DSM–IV (12). The CIDI was administered
2 months post-MI (1.8 0.6 months).
Health status. Health status was measured with the
Seattle Angina Questionnaire (SAQ) (25). The SAQ is a
19-item disease-specific self-report measure for patients
with CAD and has been used to assess patient outcomes
in acute coronary syndromes (26). It has been
demonstrated to be a valid and reproducible measure and
to be sensitive to clinical change (25,27). In addition, it
has been shown to be predictive of 1-year mortality (28).
The SAQ is composed of five scales: physical limitations
caused by CAD, angina frequency, angina stability over
the preceding month, treatment satisfaction, and patients’
perceptions of how their disease limits their quality of
life. Scores range from 0 to 100. Higher scores indicate
higher functional levels in the preceding 4 weeks, for
example, less physical limitations and better quality of life.
Demographic and clinical characteristics. Demographic
variables included gender, age, educational level, and
marital status. Clinical variables were obtained from the
patients’ medical records and included comorbidity
(arthritis, renal insufficiency, and chronic obstructive
pulmonary disease), cardiac history (MI, angina,
percutaneous coronary intervention or coronary artery
bypass graft surgery prior to the MI), multivessel disease,
diabetes mellitus, percutaneous coronary intervention
versus conservative treatment, current smoking (self-
report), and cardiac medication at discharge (b-blockers,
ACE-inhibitors, Ca-antagonists, anti-coagulants, statins,
diuretics, A2-antagonists, vasodilators, aspirin).
Statistical Analysis
Principal component analysis (PCA) with oblimin
rotation was used to determine the underlying structure
of the psychological distress measures (BDI, STAI,
GMS). A Scree-plot was adopted to identify the number
of components, and subsequent Kaiser–Meyer–Olkin
(KMO) and Bartlett’s test of sphericity were applied as
fit indexes. The resulting components were used to con-
struct homogeneous subscales of psychological distress.
For each subscale, those six items with the highest compo-
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nent loadings and cross loading differences less than .20
were selected. Subscale homogeneity was examined by
Cronbach’s alpha. Identification of groups was obtained
through cluster analysis. We used a two-stage clustering
procedure as recommended by Hair and Black (29). First,
hierarchical clustering analysis (wards method; squared
Euclidean distance) with standardized subscale measures
(M ¼ 50, SD ¼ 10) derived the number of clusters through
inspection of the agglomeration schedule. Second, the clus-
ter centers obtained from hierarchical cluster analysis were
used as initial seed points in nonhierarchical cluster analy-
sis (i.e., K-means clustering) to fine-tune the solution. The
combination of hierarchical and non-hierarchical methods
results in a more valid cluster solution. For comparison
between groups we used the chi-square test for discrete
variables and analysis of variance (ANOVA) for continu-
ous variables. A multivariate ANOVA (MANOVA) was
employed to examine differences on subscale measures
between groups identified by cluster analysis. The Stu-
dent-Neuman-Keuls test was used for post hoc analysis.
Logistic regression (method ¼ enter) was used to assess
the relationship between group membership and current
psychiatric comorbidity (i.e., MDD and=or AD). Relevant
assumptions were checked and met using the criteria
recommended by Ottenbacher et al. (30). Multiple
regression analysis (method ¼ enter) was used to assess
the relationship between group membership and health sta-
tus while controlling for potential confounders. The fol-
lowing assumptions for multiple linear regression were
checked and met (31): multicollinearity (VIF:
range ¼ 1.04–1.23), independent observations (Durbin-
Watson: range ¼ 1.85–2.10), homoscedasticity (plot of
standardized predicted dependent variable vs. standardized
residuals; random patterns were found), normally distribu-
ted error (histogram of residuals). Linearity was not
checked, because all independent variables were dichot-
omous. Data were analyzed using SPSS 12.0.1 forWindows.
RESULTS
Components of Psychological Distress
A PCA revealed a four-component solution in the
underlying structure of the psychological symptom mea-
sures (see Table 1). KMO (0.95) and Bartlett’s test of
TABLE 1
Four-Component Rotated Solution for Psychological Distress Measures
Items Scale (#) Comp-1 Comp-2 Comp-3 Comp-4
Depressed affect
Guilty feelings BDI (5)  .87
Self-dislike BDI (7)  .84
Self-criticism BDI (8)  .79
Sense of failure BDI (3)  .79
Punishment feelings BDI (6)  .61
Feelings of sadness BDI (1)  .45
Anxious apprehension
Being jittery STAI (13) .75
Feeling restless STAI (4) .75
Feeling calm STAI (1)  .73
Feeling nervous STAI (12) .72
Feeling at ease STAI (5)  .68
Being tense STAI (3) .66
Positive affect
Hard working GMS (7) .79
Lively GMS (9) .79
Enterprising GMS (13) .78
Dynamic GMS (4) .76
Active GMS (2) .74
Bright GMS (5) .73
Emotional exhaustion
Feeling tired GMS (12) .81
Feeling fatigued GMS (18) .80
Feeling tired BDI (17) .77
Feeling weakened GMS (19) .77
Feeling worn out GMS (3) .72
Feeling feeble GMS (8) .70
Note. No cross-loadings of .30 or more were found in the six-item subscales. Only the six items with the highest component loadings are shown.
Comp ¼ component. BDI ¼ Beck Depression Inventory; STAI ¼ State-Trait Anxiety Inventory; GMS ¼ Global Mood Scale.
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sphericity, v2(1830) ¼ 15,217, p < .001, N ¼ 324 indicated
that PCA was adequate for these data. The six-item sub-
scales that were constructed from the PCA reflected,
respectively, Depressed Affect (Component 3; Cronbach’s
a ¼ .82; BDI Items 1, 3, 5, 6, 7, 8), Anxious Apprehension
(Component 1; a ¼ .90; STAI Items 1, 3, 4, 5, 12, 13), Posi-
tive Affect (Component 2; a ¼ .91; GMS Items 2, 4, 5, 7, 9,
13), and Emotional Exhaustion (Component 4; a ¼ .92;
GMS Items 3, 8, 12, 18, 19; BDI Item 17). The labeling
of the components was based on previous literature
(22,23). For example, the items included in the Emotional
Exhaustion subscale were drawn from the negative affect
subscale of the GMS. The range of component loadings
for items not reported in Table 1 was .30 to .63 for Com-
ponent 1, .46 to .69 for Component 2, .30 to .41 for
Component 3, and .38 to .69 for Component 4.
Psychological distress profiles. The agglomeration
schedule obtained by hierarchical cluster analysis suggested
a three-cluster solution. There was a sharp increase in
within-cluster sum of squares between two and three
clusters. Subsequently, K-means cluster analysis resulted in
a final solution with 168 (52%) patients in the first cluster,
118 (36%) in the second cluster, and 38 (12%) in the third
cluster. Figure 1 visualizes the three psychological distress
profiles. Cluster 1 can be characterized by a relative absence
of psychological distress and presence of positive affect and
is therefore labeled the no distress group. Clusters 2 and 3
can both be labeled as increased distress groups. Cluster 2 is
characterized by low positive affect and increased anxious
apprehension=emotional exhaustion but also by the absence
of depressed affect. Cluster 3 is characterized by the
presence of psychological distress, including depressed affect
and a relative absence of positive affect.
Cluster characteristics are shown in Table 2. Patients in
Cluster 1 were more likely to be male and to have a high
FIGURE 1 Psychological symptom clusters.
TABLE 2






Age (M, SD) 60.1 (11.0) 60.0 (11.5) 56.7(11.5) .22
Male sex 89 (149) 73 (86) 68 (26) .001
Low educational leveld 72 (120) 84 (99) 84 (32) .03
Having no partner 13 (21) 14 (17) 34 (13) .004
Being a smoker 37 (61) 35 (41) 66 (25) .002
Cardiac historye 19 (31) 32 (36) 34 (13) .03
Multi-vessel diseasef 42 (67) 46 (51) 40 (15) .75
Comorbidityg 13 (20) 29 (32) 29 (11) .002
Diabetes 12 (19) 14 (16) 11 (4) .77
PCIh 63 (100) 60 (67) 63 (24) .89
b-blockers 87 (139) 85 (94) 84 (32) .84
ACE-inhibitors 40 (64) 43 (47) 32 (12) .48
Ca-antagonists 15 (24) 25 (27) 13 (5) .09
Anti-coagulants 83 (133) 85 (94) 76 (29) .49
Statins 94 (145) 94 (104) 87 (33) .40
Diuretics 18 (28) 21 (23) 29 (11) .28
A2-antagonists 8 (13) 10 (11) 8 (3) .84
Vasodilators 24 (39) 33 (37) 26 (10) .26
Aspirin) 88 (141) 77 (85) 82 (31) .06
Note. Unless noted, values are % (n). In 4% of the cases medical data were unknown. Bold indicates significant values.
a n ¼ 168. bn ¼ 118. cn ¼ 38. dNo education completed, first level (primary school), or secondary level (first phase). eMyocardial infarction (MI),
angina, percutaneous coronary intervention or coronary artery bypass graft prior to the MI. fReference group: one-vessel disease. gArthritis, renal
insufficiency, chronic obstructive pulmonary disease. hReference group: noninvasive treatment.
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educational level and less likely to have comorbidities and a
cardiac history. Cluster 2 is characterized by more females,
more patients with a low educational level, and more comor-
bidities than would be expected from the independence
hypothesis. Finally, Cluster 3 contains relatively more
females, more patients without a partner, and more current
smokers.
A MANOVA revealed that there was an overall signifi-
cant main effect for cluster membership on psychological
distress (Wilks’s lambda ¼ 0.32), F(8, 450) ¼ 42.7,
p < .0001, adjusting for sex, marital status, educational
level, smoking, cardiac history, and comorbidity. This
indicates that differences between clusters on psychological
distress variables cannot be explained by the included
covariates. Therefore, the clusters provide unique infor-
mation on the identification of subgroups in CAD
patients.
Psychological distress profiles and psychiatric
comorbidity. Because of the relative low prevalence of
MDD and AD in our sample, we created a single
dichotomous variable: psychiatric comorbidity. Value 1
was assigned to those patients with current MDD and=or
AD. The prevalence of psychiatric comorbidity was 2%
(n ¼ 3=168; MDD, n ¼ 2; AD, n ¼ 2) in Cluster 1, 9%
(n ¼ 11=118; MDD, n ¼ 10, AD, n ¼ 2) in Cluster 2, and
37% (n ¼ 14=38; MDD, n ¼ 12, AD, n ¼ 8) in Cluster 3.
Cluster membership was recoded into two dummy
variables with the no distress group as reference category.
Subsequently, logistic regression analysis revealed that
both the increased distress group with depressed affect
(Cluster 3; odds ratio ¼ 27.1; 95% confidence
interval ¼ 6.4–114.7, p < .0001) as well as the increased
distress group without depressed affect (Cluster 2; odds
ratio ¼ 5.4; 95% confidence interval ¼ 1.3–22.1, p ¼ .018)
were associated with psychiatric comorbidity (Nagelkerke
R2 ¼ 0.25; Hosmer and Lemeshow test: p ¼ 1). Hence, a
subgroup of CAD patients was more likely to have
psychiatric comorbidity despite their low levels of
self-reported depressed affect. These patients were
characterized, however, by increased levels of self-reported
anxious apprehension and emotional exhaustion and the
relative absence of positive affect. The exact strength of the
associations should be interpreted with some caution given
the large confidence intervals and the small cell sizes,
especially in Cluster 1 (the reference category).
Psychological distress profiles and health status. Mean
levels of health status were lowest among patients in
Cluster 3, whereas patients in Cluster 2 reported lower
levels of health status compared to Cluster 1 patients
(Table 3).
In multivariate analyses, all health status subscales were
associated with cluster membership. Patients in the increased
distress group with depressed affect (Cluster 3;
 .48 < b < .20; all p < .05) and the increased distress
groupwithout depressedaffect (Cluster2;  .38 < b < .12;
all p < .05) experienced decreased health status compared
with the no distress subgroup. In addition, age, current smok-
ing, aspirin usage, multivessel disease, cardiac history, and
comorbidity were also associated with decreased self-reported
health status.
DISCUSSION
The aim of the study presented here was to examine
dimensions of psychological distress in post-MI patients
and the associations of psychological symptom profiles
with psychiatric comorbidity and health status. The under-
lying structure of self-reported psychological symptoms
post-MI consisted of four components: depressed affect,
anxious apprehension, positive affect, and emotional
exhaustion. Cluster analysis based on these components
revealed three psychological symptom clusters: a no dis-
tress subgroup, characterized by a relative absence of
psychological distress and presence of positive affect, and
two increased distress subgroups characterized by absence
of positive affect and presence of anxious apprehension
and emotional exhaustion. Remarkably, one increased dis-
tress subgroup was characterized by a relative absence of
depressed affect as well. Patients in the two increased
TABLE 3






M SD M SD M SD P
Physical limitation 39.7 7.4 33.1 9.8 29.9 9.9 <.0001
Angina stability 5.6 0.9 4.8 1.5 4.3 1.6 < .0001
Angina frequency 11.5 1.3 10.6 2.0 9.8 2.5 < .0001
Treatment satisfaction 17.5 2.3 16.4 3.3 15.5 3.5 < .0001
Quality of life 12.4 2.1 9.8 2.8 7.9 3.0 < .0001
Note. Results of pairwise comparisons were all significant (p < .05). Higher scores indicate better health status, e.g. less angina frequency and
better quality of life.
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distress subgroups were more likely to have MDD=AD and
decreased health status as compared with the no distress
subgroup. This suggests that some post-MI patients may
be more likely to have MDD=AD and impaired health sta-
tus despite their low levels of self-reported depressed affect.
Moreover, these results imply that the spectrum of psycho-
logical factors associated with CAD is larger than
previously considered.
An increasing body of literature has demonstrated
a relationship between depressive symptoms and the
likelihood of subsequent adverse cardiac events (32),
although negative findings have been reported (33–35). It is
interesting to note that in our study one increased distress
subgroup without elevated scores on depressed affect, but
characterized by the absence of positive affect and presence
of anxious apprehension and emotional exhaustion, was asso-
ciated with psychiatric comorbidity and decreased health sta-
tus. This ‘‘subclinical’’ group can be an interesting study
target because it seems that these patients are more likely to
have psychiatric comorbidity and decreased health status
without having increased depressed affect. It is possible that
the absence of positive affect is important in this subgroup.
In contrast to the data linking negative emotional
states to CAD, the potential protective effect of positive
psychological factors has been less extensively investi-
gated (36), and data linking positive affect and health
is not definitive (37). In the largest study to date, parti-
cipants were assessed for optimistic versus pessimistic
explanatory style and followed for 10 years. Results
revealed a gradient relationship between levels of opti-
mism and cardiac outcomes, with optimism halving the
risk for cardiac events (38). In addition, several studies
have shown that positive psychological factors can
dampen the physiologic reactivity to negative emotional
stimuli (39) and can enhance immune function (40).
These findings point to the importance of further explor-
ing positive emotional states and their potential
protective effects against disease.
In addition, our findings show that anxious apprehen-
sion could be a potentially harmful negative emotion. Sev-
eral large studies have noted a relationship between phobic
anxiety and sudden cardiac death (41,42). In addition,
Grace et al. (18) reported nonphobic anxiety to have a
negative effect on self-reported recurrent cardiac events fol-
lowing an ischemic coronary event. However, data linking
the various forms of anxiety to CAD are relatively rare and
more work is needed.
According to Suls and Bunde (43), there needs to be
more appreciation that the clustering and overlap of nega-
tive affective dispositions may make specificity of emotion
less critical for CAD risk, that is, anxiety and depression
may not have distinctive, independent effects. They may
all increase risk because they share a general disposition
to experience chronic and intense negative emotions.
Kubzansky and colleagues (11) also argued for the need
to study various potential psychosocial risk factors and
their relationship with CAD and CAD recurrence. Identi-
fying various forms of distress, even in their less severe
states, may provide an important avenue for early inter-
vention. Effective treatment targeting psychosocial risk
factors in CAD patients requires an accurate characteriza-
tion of who is at risk for adverse outcomes. A more
detailed examination of the CAD distress profiles may bet-
ter inform the development of more effectively timed and
more specifically tailored behavioral interventions. How-
ever, more research is needed to replicate these results
and to study potential treatment implications.
Results of this study show that the increased distress
profiles were associated with MDD=AD and impaired health
status. According to the European Society of Cardiology
(44), primary goals of therapy include symptom control and
maximizing health status. In addition, health status has been
shown to be predictive of 1-year mortality (28). Understand-
ing the association of negative and positive mood states with
health status may help to guide development of interventions
to enhance health status and outcome following MI.
The results of our study should be interpreted with some
caution. Because the study was cross-sectional, we were not
able to assess the predictive value of the psychological symp-
tom clusters. It would be interesting to evaluate the effect of
the symptom clusters on cardiac morbidity and mortality.
Ultimately, these profiles will need to be examined prospec-
tively against hard medical outcomes. Furthermore, we had
no information on left ventricular ejection fraction, which
could influence psychological symptoms post-MI. However,
we did adjust for other measures of disease severity (e.g., car-
diac history). We did not take into account the potential
influence of history of psychiatric disorder. Our study also
has a number of strengths, including the use of valid and
reliable measures of multiple concepts, making it possible
to identify various underlying dimensions of psychological
symptoms post-MI. We also used a structured diagnostic
interview to assess psychiatric comorbidity. In addition,
health status was assessed with a disease-specific measure
that may be more sensitive to capture symptoms in this
patient group than a generic measure.
In conclusion, the underlying structure of self-reported
psychological symptoms post-MI can be characterized by
depressed affect, anxious apprehension, positive affect,
and emotional exhaustion. Symptom profiles based on
these features revealed a no distress subgroup and two
increased distress subgroups. Both increased distress sub-
groups were associated with psychiatric comorbidity and
decreased health status, despite the relative absence of
depressed affect in one of these subgroups. This study
needs to be replicated in a similar sample using confirma-
tory factor analysis, measures of objective health status,
and longitudinal data. The distress profiles based on the
underlying structure reported here provide a basis for
profile analysis of psychological symptom change in
outcome studies with post-MI patients and are potentially
valuable for both research and clinical practice.
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